uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. Lungmedicin och allergologi.
Show others and affiliations
2005 (English)In: J Clin Oncol, ISSN 0732-183X, Vol. 23, no 33, 8380-8 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 23, no 33, 8380-8 p.
Keyword [en]
Adult, Age Factors, Aged, Aged; 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use, Carboplatin/administration & dosage/adverse effects, Carcinoma; Non-Small-Cell Lung/*drug therapy/mortality/pathology, Comparative Study, Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives, Disease-Free Survival, Female, Humans, Lung Neoplasms/*drug therapy/mortality/pathology, Male, Middle Aged, Proportional Hazards Models, Quality of Life, Research Support; Non-U.S. Gov't, Statistics; Nonparametric, Survival Analysis, Sweden/epidemiology
URN: urn:nbn:se:uu:diva-80495PubMedID: 16293868OAI: oai:DiVA.org:uu-80495DiVA: diva2:108409
Available from: 2006-05-22 Created: 2006-05-22 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 153 hits
ReferencesLink to record
Permanent link

Direct link